Strumento inattivo

Azioni AveXis Inc

Azioni

Durata

Periodo

Stile

Novartis : top lawyer exits over Trump attorney deal 'mistake'	16/05/18
Novartis : top lawyer exits over Trump attorney deal 'mistake'	16/05/18
AveXis Reports First Quarter 2018 Financial and Operating Results	03/05/18
AveXis Provides Update on Proposed Acquisition by Novartis AG	01/05/18
AveXis Announces First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3	25/04/18

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31%	103 Mrd
REGENERON PHARMACEUTICALS, INC.	+0,56%	95,28 Mrd
ARGENX SE	+1,69%	22,15 Mrd
BIONTECH SE	-17,37%	21,02 Mrd
GENMAB A/S	-9,30%	18,15 Mrd
WUXI APPTEC CO., LTD.	-41,01%	16,74 Mrd
BEIGENE, LTD.	-14,85%	16,05 Mrd
NEUROCRINE BIOSCIENCES, INC.	+3,21%	13,68 Mrd
SAREPTA THERAPEUTICS, INC.	+33,54%	12,17 Mrd